Skip To Main Content
Abdullah Yusuf on Muck Rack

Abdullah Yusuf

As seen in: Yahoo Canada, Yahoo News Malaysia, Memory Studies, PLOS ONE, The Conversation, Firstpost, CNA (Channel NewsAsia), Business Standard, Yahoo, SBS and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Abdullah

Contact Abdullah, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Age at dementia diagnosis, subtype associations, and neuroimaging differentiation in Bangladesh: The CARED study

|
By Redoy Ranjan, Ghulam Kawnayn, Abdullah Yusuf
| PLOS ONE
Loading metrics Open Access Peer-reviewed Research Article Citation: Ranjan R, Kawnayn G, Yusuf MA, Uddin MN, Mamun MT, Al Mamun A, et al. (2026) Age at dementia diagnosis, subtype associations, and neuroimaging differentiation in Bangladesh: The CARED study. PLoS One 21(9): e0359109.
Open in Who Shared Issue with article?

10.000 Pengunjung Ramaikan Kampung Cempluk Festival ke-15: Tradisi, Musik, dan Kreativitas Bersatu

|
By Abdullah Yusuf
| Kompasiana Verified
Dusun Sumberjo, Desa Kalisongo, Kecamatan Dau, Kabupaten Malang, kembali hidup oleh keriuhan Kampung Cempluk Festival ke-15, yang digelar selama enam hari, 6–11 Oktober 2025. Festival ini menghadirkan rangkaian kegiatan budaya, termasuk pawai, pertunjukan musik dan tarian, serta Pasar Jajanan Tempo Dulu, dengan tujuan memperkenalkan, melestarikan, dan mengapresiasi kebudayaan lokal sekaligus meningkatkan perputaran ekonomi masyarakat.
Open in Who Shared Issue with article?

A revolutionary HIV drug won't matter if patients can't afford it

|
By Abdullah Yusuf
| Devex
The Trump administration’s announcement earlier this month of investment in lenacapavir — a groundbreaking HIV prevention drug requiring just two injections per year — represents a pivotal moment in HIV prevention. But even as officials work to bring the drug's price down to $100 per person annually by 2025, and eventually to $40 as early as 2027, a crucial challenge remains: How do we ensure this lifesaving medication actually reaches the people who need it most?
Open in Who Shared Issue with article?
See all 40 licensed articles (41 Total)